Financials Thermo Fisher Scientific Inc.

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 01:07:18 2024-12-06 pm EST			5-day change	1st Jan Change
530.49 ^USD	+1.85%		+0.05%	-0.17%

Dec. 04	Thermo Fisher Scientific Insider Sold Shares Worth $10,624,559, According to a Recent SEC Filing	MT
Dec. 04	Thermo Fisher Scientific Launches CTS? Detachable Dynabeads? CD4 and CTS Detachable Dynabeads CD8 to Enhance Cell Therapy Development and Production	CI

Projected Income Statement: Thermo Fisher Scientific Inc.

income-statement-evolution-chart THERMO-FISHER-SCIENTIFIC-

Fiscal Period: december	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	25,542	32,218	39,211	44,915	42,857	42,813	45,111	48,443
Change	-	26.14%	21.71%	14.55%	-4.58%	-0.1%	5.37%	7.39%
EBITDA ¹	6,537	10,214	12,969	11,971	10,878	10,800	11,531	12,675
Change	-	56.25%	26.97%	-7.7%	-9.13%	-0.72%	6.77%	9.92%
EBIT ¹	5,973	9,556	12,138	10,985	9,810	9,703	10,415	11,423
Change	-	59.99%	27.02%	-9.5%	-10.7%	-1.09%	7.33%	9.68%
Interest Paid ¹	-676	-553	-536	-726	-1,375	-1,420	-1,313	-1,160
Earnings before Tax (EBT) ¹	4,070	7,225	8,841	7,835	6,298	6,923	7,809	9,066
Change	-	77.52%	22.37%	-11.38%	-19.62%	9.93%	12.79%	16.09%
Net income ¹	3,696	6,375	7,725	6,950	5,995	6,143	6,943	8,069
Change	-	72.48%	21.18%	-10.03%	-13.74%	2.46%	13.03%	16.22%
Announcement Date	1/30/20	2/1/21	2/2/22	2/1/23	1/31/24	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3
Net sales ¹	6,829	6,230	6,917	8,521	10,550	9,906	9,273	9,330	10,702	11,818	10,970	10,677	11,450	10,710	10,687	10,574	10,886	10,345	10,541	10,598	11,298	10,795	11,100	11,187	11,962	11,554	11,910	12,063
Change	-	-8.77%	11.03%	23.19%	23.81%	-6.1%	-6.39%	0.61%	14.71%	10.43%	-7.18%	-2.67%	7.24%	-6.46%	-0.21%	-1.06%	2.95%	-4.97%	1.89%	0.54%	6.6%	-4.45%	2.82%	0.79%	6.92%	-3.4%	3.08%	1.29%
EBITDA ¹	1,846	1,526	2,021	2,964	3,703	3,708	2,900	2,983	3,378	3,700	2,841	2,614	2,816	2,583	2,640	2,829	2,826	2,564	2,623	2,653	2,933	2,709	2,812	2,835	3,137	2,900	3,057	3,113
Change	-	-17.33%	32.44%	46.66%	24.93%	0.14%	-21.79%	2.86%	13.24%	9.53%	-23.22%	-7.99%	7.73%	-8.27%	2.21%	7.16%	-0.11%	-9.27%	2.3%	1.14%	10.56%	-7.64%	3.78%	0.85%	10.63%	-7.54%	5.42%	1.82%
EBIT ¹	1,698	1,377	1,864	2,803	3,512	3,510	2,689	2,778	3,161	3,450	2,605	2,370	2,560	2,330	2,370	2,560	2,550	2,278	2,347	2,362	2,680	2,437	2,531	2,553	2,831	2,662	2,777	2,801
Change	-	-18.9%	35.37%	50.38%	25.29%	-0.06%	-23.39%	3.31%	13.79%	9.14%	-24.49%	-9.02%	8.02%	-8.98%	1.72%	8.02%	-0.39%	-10.67%	3.03%	0.64%	13.46%	-9.05%	3.84%	0.86%	10.9%	-5.97%	4.34%	0.84%
Charge d'intérêts ¹	-142	-126	-137	-144	-146	-125	-122	-128	-161	-136	-148	-173	-269	-300	-326	-359	-390	-363	-354	-356	-366.8	-348.3	-342.5	-334.8	-326.8	-	-	-
Earnings before Tax (EBT) ¹	-	-	-	2,252	-	-	2,047	2,173	1,862	2,540	1,917	1,601	1,777	1,363	1,430	1,765	1,740	1,589	1,765	1,742	1,869	1,700	1,827	1,910	2,267	1,783	1,980	2,085
Change	-	-	-	-	-100%	-	-	6.16%	-14.31%	36.41%	-24.53%	-16.48%	10.99%	-23.3%	4.92%	23.43%	-1.42%	-8.68%	11.08%	-1.3%	7.29%	-9.04%	7.47%	4.57%	18.66%	-21.35%	11.05%	5.3%
Net income ¹	1,002	788	1,156	1,933	2,498	2,337	1,828	1,902	1,658	2,215	1,664	1,495	1,576	1,289	1,361	1,715	1,630	1,328	1,548	1,630	1,793	1,535	1,662	1,708	2,024	1,571	1,747	1,842
Change	-	-21.36%	46.7%	67.21%	29.23%	-6.45%	-21.78%	4.05%	-12.83%	33.59%	-24.88%	-10.16%	5.42%	-18.21%	5.59%	26.01%	-4.96%	-18.53%	16.57%	5.3%	10.01%	-14.42%	8.3%	2.75%	18.53%	-22.38%	11.2%	5.44%
Announcement Date	1/30/20	4/22/20	7/22/20	10/21/20	2/1/21	4/29/21	7/28/21	10/27/21	2/2/22	4/28/22	7/28/22	10/26/22	2/1/23	4/26/23	7/26/23	10/25/23	1/31/24	4/24/24	7/24/24	10/23/24	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Thermo Fisher Scientific Inc.

balance-sheet-analysis-chart THERMO-FISHER-SCIENTIFIC-

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	15,353	11,410	30,393	25,964	26,840	25,821	20,282	13,543
Change	-	-25.68%	166.37%	-14.57%	3.37%	-3.8%	-21.45%	-33.23%
Announcement Date	1/30/20	2/1/21	2/2/22	2/1/23	1/31/24	-	-	-

¹USD in Million

Estimates

Cash Flow Forecast: Thermo Fisher Scientific Inc.

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
CAPEX ¹	926	1,474	2,523	2,243	1,479	1,370	1,486	1,585
Change	-	59.18%	71.17%	-11.1%	-34.06%	-7.38%	8.47%	6.7%
Free Cash Flow (FCF) ¹	4,047	6,815	7,020	6,935	6,927	6,980	8,665	9,549
Change	-	68.4%	3.01%	-1.21%	-0.12%	0.76%	24.15%	10.2%
Announcement Date	1/30/20	2/1/21	2/2/22	2/1/23	1/31/24	-	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: Thermo Fisher Scientific Inc.

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Profitability
EBITDA Margin (%)	25.59%	31.7%	33.07%	26.65%	25.38%	25.22%	25.56%	26.16%
EBIT Margin (%)	23.39%	29.66%	30.96%	24.46%	22.89%	22.66%	23.09%	23.58%
EBT Margin (%)	15.93%	22.43%	22.55%	17.44%	14.7%	16.17%	17.31%	18.71%
Net margin (%)	14.47%	19.79%	19.7%	15.47%	13.99%	14.35%	15.39%	16.66%
FCF margin (%)	15.84%	21.15%	17.9%	15.44%	16.16%	16.3%	19.21%	19.71%
FCF / Net Income (%)	109.5%	106.9%	90.87%	99.78%	115.55%	113.62%	124.81%	118.34%
Profitability
ROA	8.7%	12.26%	9.43%	9.52%	8.54%	7.68%	8.32%	8.6%
ROE	17.38%	24.34%	26.52%	21.61%	18.43%	17.33%	17.11%	17.53%
Financial Health
Leverage (Debt/EBITDA)	2.35x	1.12x	2.34x	2.17x	2.47x	2.39x	1.76x	1.07x
Debt / Free cash flow	3.79x	1.67x	4.33x	3.74x	3.87x	3.7x	2.34x	1.42x
Capital Intensity
CAPEX / Current Assets (%)	3.63%	4.58%	6.43%	4.99%	3.45%	3.2%	3.29%	3.27%
CAPEX / EBITDA (%)	14.17%	14.43%	19.45%	18.74%	13.6%	12.68%	12.89%	12.51%
CAPEX / FCF (%)	22.88%	21.63%	35.94%	32.34%	21.35%	19.63%	17.15%	16.6%
Items per share
Cash flow per share ¹	12.34	20.77	24.04	23.23	21.66	21.21	26.49	29.64
Change	-	68.35%	15.71%	-3.35%	-6.75%	-2.11%	24.92%	11.89%
Dividend per Share ¹	0.76	0.88	1.04	1.2	1.4	1.492	1.598	1.735
Change	-	15.79%	18.18%	15.38%	16.67%	6.57%	7.13%	8.52%
Book Value Per Share ¹	74.19	86.48	103.4	112.6	120.9	130.7	142.9	156.6
Change	-	16.57%	19.58%	8.89%	7.33%	8.12%	9.36%	9.57%
EPS ¹	9.17	15.96	19.46	17.63	15.45	16.28	18.27	21.27
Change	-	74.05%	21.93%	-9.4%	-12.37%	5.39%	12.19%	16.43%
Nbr of stocks (in thousands)	400,991	396,335	394,048	394,048	386,372	382,500	382,500	382,500
Announcement Date	1/30/20	2/1/21	2/2/22	2/1/23	1/31/24	-	-	-